Long COVID as a concept emerged in late spring 2020 as people reported ongoing symptoms long after initial infection with the SARS-CoV-2 virus.1
By December, around 1 in 5 people testing positive for COVID-19 said they were experiencing symptoms for 5 weeks or longer, while around 1 in 10 had symptoms for 12 weeks or longer. This equated to approximately 186,000 people at that moment living with symptoms that had persisted for between 5 and 12 weeks.2
To better understand prevalence, NICE analysed data from 23 studies from around the world relating to people experiencing symptoms 4-12 weeks after initial infection. This included people who had been admitted to hospital with COVID-19 (n=142 to 950) and those who had not (n=670 to 3,770).3
The combined results show a wide range of values for individual symptom
Long COVID as a concept emerged in late spring 2020 as people reported ongoing symptoms long after initial infection with the SARS-CoV-2 virus.1
By December, around 1 in 5 people testing positive for COVID-19 said they were experiencing symptoms for 5 weeks or longer, while around 1 in 10 had symptoms for 12 weeks or longer. This equated to approximately 186,000 people at that moment living with symptoms that had persisted for between 5 and 12 weeks.2
To better understand prevalence, NICE analysed data from 23 studies from around the world relating to people experiencing symptoms 4-12 weeks after initial infection. This included people who had been admitted to hospital with COVID-19 (n=142 to 950) and those who had not (n=670 to 3,770).3
The combined results show a wide range of values for individual symptoms;
Symptom | Prevalence among hospitalised (range %) | Prevalence among non-hospitalised |
Shortness of breath | 32%-74% | 8% to 71% |
Fatigue | 28%-68% | 27%-87% |
Cough | 7%-43% | |
Sleep disturbance | 18%-57% | |
Cognitive impairment | 18%-22% | 2%-29% |
Sore throat | 3%-9% | |
Loss of smell | 12%-15% | 7%-51% |
Loss of taste | 9%-10% | 5%-51% |
Chest pain | 6.9%-44% | |
Joint pain | 2%-31% | |
Headache | 5%-38% | |
Palpitations | 10%-32% | |
Fever | 2%-11% |